Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
ACS Medicinal Chemistry Letters|October 15, 2025
Discovery of the U2AF1-UHM Inhibitor That Possesses Anti-Leukemia Activity In VitroAmol D Patil, Mona Kazemi Sabzvar, Xinrui Yuan, et al.
ACS Medicinal Chemistry Letters|April 20, 2023
Profiling the Binding Activities of Peptides and Inhibitors to the U2 Auxiliary Factor Homology Motif (UHM) DomainsXinrui Yuan, Kathryn L Howie, Mona Kazemi Sabzvar, et al.
ACS Medicinal Chemistry Letters|May 17, 2023
Correction to "Profiling the Binding Activities of Peptides and Inhibitors to the U2 Auxiliary Factor Homology Motif (UHM) Domains"Xinrui Yuan, Kathryn L Howie, Mona Kazemi Sabzvar, et al.
Cellular Signalling|September 8, 2025
An inhibitor of UHM splicing factors exerts anti-leukemic activity by altering cell cycle progression and reducing lysosome acidificationMona Kazemi Sabzvar, Eun Bee Cho, Xinrui Yuan, et al.
Research Square|June 17, 2024
Comprehensive Analyses of the Effects of the Small-Molecule Inhibitor of the UHM Domain in the Splicing Factor U2AF1 in Leukemia CellsXinrui Yuan, Mona Kazemi Sabzvar, Amol D Patil, et al.
ACS Medicinal Chemistry Letters|November 20, 2024
Studies of Structure-Activity Relationship of 2-(Pyrrolidin-1ylmethyl)-1H-pyrrole-Based ST2 Inhibitors and Their Inhibition of Mast Cells ActivationXinrui Yuan, Jason C Rech, Andhavaram Ramaraju, et al.
Pageof 1